Live Breaking News & Updates on Capital Fund One

Stay updated with breaking news from Capital fund one. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Negev Capital Fund One, L.P. Reports Updated Holdings in Filament Health Corp.

Negev Capital Fund One, L.P. , a shareholder of Filament Health Corp. , announces that on June 12, 2024, it was issued 42,284,443 common shares of Filament from the conversion of a convertible note. ....

Vancouver , British-columbia , Canada , United-kingdom , British , Vadim-uzberg , Filament-health-corp , British-columbia-newsfile-corp , Negev-capital-fund , Capital-fund-one , Filament-health , Common-shares

FILAMENT HEALTH ANNOUNCES CLOSING OF WARRANT EXERCISE, NOTE CONVERSION AND CONCURRENT PRIVATE PLACEMENT OF COMMON SHARES

FILAMENT HEALTH ANNOUNCES CLOSING OF WARRANT EXERCISE, NOTE CONVERSION AND CONCURRENT PRIVATE PLACEMENT OF COMMON SHARES
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Vancouver , British-columbia , Canada , Canadian , Benjamin-lightburn , Instagram , Filament-health , Negev-capital-fund , Twitter , Founder-of-the-company , Linkedin , Company-common

Chemomab Therapeutics : Notice and Proxy Statement with respect to the Company's annual general meeting of the shareholders (the "Meeting") to be held on June 10, 2024, describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other details related to the meeting - Form 6-K

May 3, 2024

Dear Chemomab Therapeutics Ltd. Shareholders:

We cordially. ....

Tel-aviv , Israel , North-carolina , United-states , Missouri , Hahoshlim , Ha-afon , Washington-university , Ramat-gan , Delaware , Duke-university , American

Chemomab Therapeutics : Notice and Proxy Statement with respect to the Company's annual general meeting of the shareholders (the "Meeting") to be held on August 7, 2023, describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other details related to the meeting

July 3, 2023

Dear Chemomab Therapeutics Ltd. Shareholders:

We cordially. ....

Brussels , Bruxelles-capitale , Belgium , Herzliya , Tel-aviv , Israel , Jerusalem , Israel-general , Ramat-gan , United-states , Castries , Saint-lucia